{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-08T16:42:14.894737+00:00",
  "news": [
    {
      "title": "Vertex Stock Tumbles After Strong Earnings. What’s Spooking Investors. - Barron's",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTE9qWGRSNktzc2pwaVZZZnhCbHlHcmJSVTJtQ2dEa00wYXAwZWJEZjBoYVc1SkNoUlh1dlB1OTZ4b01aWWxjQWZfeV93RXU5OGp4M3ZYWlB1RVFSZW05V3Z4b3JqRy1QckhtSzJIeTlqYWJ2TEwxS3p6MXBld2NkRXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTE9qWGRSNktzc2pwaVZZZnhCbHlHcmJSVTJtQ2dEa00wYXAwZWJEZjBoYVc1SkNoUlh1dlB1OTZ4b01aWWxjQWZfeV93RXU5OGp4M3ZYWlB1RVFSZW05V3Z4b3JqRy1QckhtSzJIeTlqYWJ2TEwxS3p6MXBld2NkRXc?oc=5\" target=\"_blank\">Vertex Stock Tumbles After Strong Earnings. What’s Spooking Investors.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Barron's</font>",
      "published": "2025-08-05T14:12:00+00:00",
      "source": "Barron's"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcUVzV3lfWk9fdVV2Sm1oaGFRR3pjbWs1UWlEVmdpN3RLcjhaZ2gwT3M2aC1menVva0NuS0NPZVFqVlFETTFRazdBWW1MVUlZc01RbTFRQ2F5RWZ6QXBUaDg4NkphSVNqcl9XLWtxOW5JSlpoalVEc1dyb1NaWG5VSkpySFpyWlYtT1Rz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcUVzV3lfWk9fdVV2Sm1oaGFRR3pjbWs1UWlEVmdpN3RLcjhaZ2gwT3M2aC1menVva0NuS0NPZVFqVlFETTFRazdBWW1MVUlZc01RbTFRQ2F5RWZ6QXBUaDg4NkphSVNqcl9XLWtxOW5JSlpoalVEc1dyb1NaWG5VSkpySFpyWlYtT1Rz?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Hits New All-Time Low on Failed Clinical Trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-06T16:23:20+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNRURkTWw0Y1VEdmRxSGQwYXEwUzlZbTd6Q1ZLaVVmMkpaVmU1eG9weWpsRlZ5WDJpVzBvaU9kRWpkRHd2blVJczVxNktTdkc3bFRvTmFkeURoc05NY2QtQ2xzYVQ5cWJad3kwSGxHQTR1MHh2dUZUUzZsc25XdWhWaUpDeWVVOXg2MmVRZU55RTBMVU40MzAybw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNRURkTWw0Y1VEdmRxSGQwYXEwUzlZbTd6Q1ZLaVVmMkpaVmU1eG9weWpsRlZ5WDJpVzBvaU9kRWpkRHd2blVJczVxNktTdkc3bFRvTmFkeURoc05NY2QtQ2xzYVQ5cWJad3kwSGxHQTR1MHh2dUZUUzZsc25XdWhWaUpDeWVVOXg2MmVRZU55RTBMVU40MzAybw?oc=5\" target=\"_blank\">7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-08-06T08:42:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T13:52:29+00:00",
      "source": "Investopedia"
    },
    {
      "title": "Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNa29lMEJqdk1mYm4ycTltcXBaTUprcW5vTFJNRjZzN092anY2Z3AteTVsbTh6MTM1Q3dTT2R6NEd3elVJRnRMZFYyZlNFdGpxeHZwdUxUNTZveWtlS2RVUXIyZDJkZ2p4ZjB4eTFUZ01qMTBuT1dDVHBMVXZQRnRldWdmTFVvYVFqLWNkclU3SzAyYW5JMkZOQXNOcnN1LU9VUTBLNHkxZFkyMXB4TEEzQnM4c0tuanJqMjFPeGRRSXE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNa29lMEJqdk1mYm4ycTltcXBaTUprcW5vTFJNRjZzN092anY2Z3AteTVsbTh6MTM1Q3dTT2R6NEd3elVJRnRMZFYyZlNFdGpxeHZwdUxUNTZveWtlS2RVUXIyZDJkZ2p4ZjB4eTFUZ01qMTBuT1dDVHBMVXZQRnRldWdmTFVvYVFqLWNkclU3SzAyYW5JMkZOQXNOcnN1LU9VUTBLNHkxZFkyMXB4TEEzQnM4c0tuanJqMjFPeGRRSXE?oc=5\" target=\"_blank\">Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-08-08T16:13:27+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Meet Reshma Kewalramani who joins the list of 100 Most Powerful People in Business 2025 alongside Jensen - The Times of India",
      "link": "https://news.google.com/rss/articles/CBMirwJBVV95cUxQTHNIZTFPMWRvRXFNSTZVY0d4X3U2TGZoMVNNX3l3ZWZEVnZVZEd2V1Y4QXVDbXRKb21RdWhYNjlmdXhUS21ocG03WDFtOERLWC1iaUpCR2w5WGxGVmxUQ19rT0ZidTFsRXlLY1paTkNhck53c01rQ3MtWU9aTm1KWmZIMF9zcThONTRlQjQzZGFXaFdvTFlsREdrY0ZqSGFNZHZ6VVhfRWtwdHhWVTVxaTRXVEZDYnpYdDlraWlMbHNsYXI3bHhZZlh1M0RYeUFnZHNjTkRMUDBPYllHc0Z6X0tlYVVFS3ZUUzJjbEczU3gzSHBFbTJfVmZWWVpnY0l5V3cxVnVSNGVtSHVLTFpOVnBiZTQ1UUprbld5Nzdad0FPcURFUmVxaVZWOTdCeG_SAbQCQVVfeXFMUGIxTDBTdTdVOU5rSy11NW81WnNmYU9VWnZxb2VveWVUV2JVSUdlcWR2ZXFudGhfZ0FxQTJKd1RCbkttWUliOG40OFl4RGtZdkI1NG83SjZhckpzUUhqalZtNVFHTG1Lc2IzdXZMaW5qMjJ0aDRqcmNScHBMNUN1RjA3cEExdEtERDFlaTBQVVlCTUlycWJhaW14dm8tbjI1eU1DQndjZTRDS2t4Z2NvdDhGV212TzBrNEJwM1hrdTFyUU1xVGYwdjZlbzQ4MUQzVG1kQzdEUExmY1pOSlBYMklfa09rbWF5NEVxQW5LVDlmTHpWWjBPTVFJWkZjR3hZLU41NWJVU2wwRzVLZjlpZUlUVHUyVW82MkxWUUtrdllLLUdYRF92b1pKckNjaUdvbWJsNTY?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwJBVV95cUxQTHNIZTFPMWRvRXFNSTZVY0d4X3U2TGZoMVNNX3l3ZWZEVnZVZEd2V1Y4QXVDbXRKb21RdWhYNjlmdXhUS21ocG03WDFtOERLWC1iaUpCR2w5WGxGVmxUQ19rT0ZidTFsRXlLY1paTkNhck53c01rQ3MtWU9aTm1KWmZIMF9zcThONTRlQjQzZGFXaFdvTFlsREdrY0ZqSGFNZHZ6VVhfRWtwdHhWVTVxaTRXVEZDYnpYdDlraWlMbHNsYXI3bHhZZlh1M0RYeUFnZHNjTkRMUDBPYllHc0Z6X0tlYVVFS3ZUUzJjbEczU3gzSHBFbTJfVmZWWVpnY0l5V3cxVnVSNGVtSHVLTFpOVnBiZTQ1UUprbld5Nzdad0FPcURFUmVxaVZWOTdCeG_SAbQCQVVfeXFMUGIxTDBTdTdVOU5rSy11NW81WnNmYU9VWnZxb2VveWVUV2JVSUdlcWR2ZXFudGhfZ0FxQTJKd1RCbkttWUliOG40OFl4RGtZdkI1NG83SjZhckpzUUhqalZtNVFHTG1Lc2IzdXZMaW5qMjJ0aDRqcmNScHBMNUN1RjA3cEExdEtERDFlaTBQVVlCTUlycWJhaW14dm8tbjI1eU1DQndjZTRDS2t4Z2NvdDhGV212TzBrNEJwM1hrdTFyUU1xVGYwdjZlbzQ4MUQzVG1kQzdEUExmY1pOSlBYMklfa09rbWF5NEVxQW5LVDlmTHpWWjBPTVFJWkZjR3hZLU41NWJVU2wwRzVLZjlpZUlUVHUyVW82MkxWUUtrdllLLUdYRF92b1pKckNjaUdvbWJsNTY?oc=5\" target=\"_blank\">Meet Reshma Kewalramani who joins the list of 100 Most Powerful People in Business 2025 alongside Jensen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Times of India</font>",
      "published": "2025-08-08T08:29:00+00:00",
      "source": "The Times of India"
    },
    {
      "title": "Vertex Pharmaceuticals stock falls as pain drug fails in phase 2 (VRTX:NASDAQ) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQd0cybWZfaWhIaWhXQUVCemw1QzIteFlPaXNHSElIYWdVakktNC16Z2c0NzFNTnkySS1CS01Mam1tMUwtdnpvMEpTb3ZKRERhQlJGd081Ym1WTFZ4Y3hSSUU0TmlpbGJLSjRJQ3h6OWU4czdvdTFOcnJ2THdxRlp4TEFEM2VQT1JMLU9SUmppSVdtOHlIRTFPVWQ5MUstcWZtS3RUOQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxQd0cybWZfaWhIaWhXQUVCemw1QzIteFlPaXNHSElIYWdVakktNC16Z2c0NzFNTnkySS1CS01Mam1tMUwtdnpvMEpTb3ZKRERhQlJGd081Ym1WTFZ4Y3hSSUU0TmlpbGJLSjRJQ3h6OWU4czdvdTFOcnJ2THdxRlp4TEFEM2VQT1JMLU9SUmppSVdtOHlIRTFPVWQ5MUstcWZtS3RUOQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals stock falls as pain drug fails in phase 2 (VRTX:NASDAQ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-05T08:12:56+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex narrows near-term development plan for Journavx after FDA naysays broad label in neuropathic pain - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWFlSWIwX3ZQY3pqcklHdVlrd3RvRjR2WHBzZjVyeVRvV05sQVR0LW4zcjZ5aDZXczlhd2k2cWRNcnVmYmotY0J2R2o1dWoxMGFjQ0pPaWVzSWZkdk5yMTJIcTB0M0JIWE5pR2ExS0tGNmd4SE5YR204SzRUWFZLUFhxV0RLSW5VRkxRR0tSazZmMF9hNk5JNG9xTWNzYmFtS3ZuMjc4dmdhYlZpVk9GeGx2ZVZVQXhTOW5xTGkydC1iRnpMdVY4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxNRWFlSWIwX3ZQY3pqcklHdVlrd3RvRjR2WHBzZjVyeVRvV05sQVR0LW4zcjZ5aDZXczlhd2k2cWRNcnVmYmotY0J2R2o1dWoxMGFjQ0pPaWVzSWZkdk5yMTJIcTB0M0JIWE5pR2ExS0tGNmd4SE5YR204SzRUWFZLUFhxV0RLSW5VRkxRR0tSazZmMF9hNk5JNG9xTWNzYmFtS3ZuMjc4dmdhYlZpVk9GeGx2ZVZVQXhTOW5xTGkydC1iRnpMdVY4?oc=5\" target=\"_blank\">Vertex narrows near-term development plan for Journavx after FDA naysays broad label in neuropathic pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-05T14:55:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T21:40:32+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Growth and Strategic Advances - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxORGtLZUtKRE5VMFp1WV9YQ3VFU2QySUg0c3pYQjIxNXFDTzlldmw3SGF5emctdmxCWVllTTgyUThPUU1xTkNDRUx2a1ZUTWxUUzg0VVMxd0YzVXJTelFPYk0xdDZHa0pobUJPcVRnenlldm05d2NoTzlPc21vamI5QTVaRTk5UVRDaGRpYm1BbjZPM1h3bWtrMkxueUg0azRQdmwzRi1UMHVsWldERzBQQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxORGtLZUtKRE5VMFp1WV9YQ3VFU2QySUg0c3pYQjIxNXFDTzlldmw3SGF5emctdmxCWVllTTgyUThPUU1xTkNDRUx2a1ZUTWxUUzg0VVMxd0YzVXJTelFPYk0xdDZHa0pobUJPcVRnenlldm05d2NoTzlPc21vamI5QTVaRTk5UVRDaGRpYm1BbjZPM1h3bWtrMkxueUg0azRQdmwzRi1UMHVsWldERzBQQw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Growth and Strategic Advances</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-06T00:26:42+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-08-04T20:01:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharmaceuticals' Q2 2025: Unpacking Contradictions in JOURNAVX Strategy, Trial Timelines, and Market Dynamics - AInvest",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcWNEMnctWDJfYzdsYVNWM0RvVFFfSFZieTFPa1Y2YmhJWnVUUmVVMjZ4V0U2bnpXLUtWd28yQVJiU0V2MS1kaldabjFIODFUNnpNcWZwRU9fRXVFUjZXYzhLNEtMZnFaVW10LXhDeGlPT2xQLVJUQmMxRi1ac3lPTlZGV3U3QWN2ZEg3NkRqZW5KcmJ2c2lIZ2NJQzQ1UlhoOFNMblFWbVFxdFVrZmNjNU9faGlxdFpxZDlZbkl3OWFoS0plM2FrajJ3Q25xVkRXLWg5Unpvbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQcWNEMnctWDJfYzdsYVNWM0RvVFFfSFZieTFPa1Y2YmhJWnVUUmVVMjZ4V0U2bnpXLUtWd28yQVJiU0V2MS1kaldabjFIODFUNnpNcWZwRU9fRXVFUjZXYzhLNEtMZnFaVW10LXhDeGlPT2xQLVJUQmMxRi1ac3lPTlZGV3U3QWN2ZEg3NkRqZW5KcmJ2c2lIZ2NJQzQ1UlhoOFNMblFWbVFxdFVrZmNjNU9faGlxdFpxZDlZbkl3OWFoS0plM2FrajJ3Q25xVkRXLWg5Unpvbw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' Q2 2025: Unpacking Contradictions in JOURNAVX Strategy, Trial Timelines, and Market Dynamics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-05T01:37:26+00:00",
      "source": "AInvest"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "latest": {
      "date": "2025-08-08",
      "close": 368.2300109863281
    },
    "history": [
      {
        "date": "2025-07-31",
        "close": 456.8699951171875
      },
      {
        "date": "2025-08-01",
        "close": 462.1300048828125
      },
      {
        "date": "2025-08-04",
        "close": 472.2699890136719
      },
      {
        "date": "2025-08-05",
        "close": 374.9800109863281
      },
      {
        "date": "2025-08-06",
        "close": 385.6499938964844
      },
      {
        "date": "2025-08-07",
        "close": 375.6300048828125
      },
      {
        "date": "2025-08-08",
        "close": 368.2300109863281
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}